Five children, including three girls and two boys, who were in the age group of 2-6 years were given the Covid vaccine in Kanpur Dehat during the ongoing trial of Bharat Biotech's Covaxin on children.
Antibody Production More With Covishield Compared to Covaxin
Study by Indian doctors says that both Covaxin & Covishield are effective, but, Covishield shows ‘significantly higher’ seropositivity rate & anti-spike antibody titre.
Study by Indian doctors says that both Covaxin & Covishield are effective, but, Covishield shows ‘significantly higher’ seropositivity rate & anti-spike antibody titre.
‘Drugs Controller General of India (DCGI) had granted permission to Bharat Biotech in the month of May to begin phase 2-3 trials of Covaxin on children as young as two.’
The spokesperson of the Prakhar hospital, where the girl was vaccinated, said on Thursday that around five children, including three girls and two boys, in the age group of 2-6 years were given the vaccine at the hospital in Kanpur. The children were kept under observation for two hours before they were allowed to go home, said the spokesperson.
A safety profile of the children, who have been vaccinated, will be prepared.
Covaxin Offers Protection Against New COVID-19 Variants
Bharat Biotech's Covaxin demonstrates protection against the new Covid-19 variants, says new study. A modest reduction in neutralisation was observed against B1617 variant compared to vaccine variant.
Bharat Biotech's Covaxin demonstrates protection against the new Covid-19 variants, says new study. A modest reduction in neutralisation was observed against B1617 variant compared to vaccine variant.
Several hospitals, including AIIMS Delhi and Patna have also commenced Covaxin trial on kids.
Advertisement
Covid-19: Demand for Covaxin Grows Among Indians
India has administered over 2 crore vaccine doses so far and is giving away millions of doses of Covid-19 vaccines to other countries.
India has administered over 2 crore vaccine doses so far and is giving away millions of doses of Covid-19 vaccines to other countries.
Source-IANS
PETA Urges DCGI to Replace Calf Serum Method for Production of Covaxin
Covaxin, India's indigenous Covid-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), uses Newborn Calf Serum (NBCS) during the production stage, which is extracted from the blood of slaughtered calves under 20 days old.
Covaxin, India's indigenous Covid-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), uses Newborn Calf Serum (NBCS) during the production stage, which is extracted from the blood of slaughtered calves under 20 days old.
